BofA Securities Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Announces Target Price $24

Moomoo NewsJan 6 06:31 ET · Ratings

Travere Therapeutics Insider Sold Shares Worth $258,278, According to a Recent SEC Filing

MT NewswiresDec 30, 2024 04:05 ET

J.P. Morgan's Top Healthcare Stocks for 2025

Seeking AlphaDec 20, 2024 11:30 ET

Stifel Maintains Travere Therapeutic(TVTX.US) With Hold Rating, Raises Target Price to $18

Moomoo NewsDec 16, 2024 21:32 ET · Ratings

The 3.8% Return This Week Takes Travere Therapeutics' (NASDAQ:TVTX) Shareholders One-year Gains to 124%

Simply Wall StDec 6, 2024 06:14 ET

In 2025, US Biotech stocks are expected to rise significantly. jpmorgan's top pick is vertex pharmaceuticals (VRTX.US).

Vertex pharmaceuticals (Vertex) ranked first on the list of US biotechnology stock selections for 2025 released by jpmorgan.

Zhitong FinanceNov 26, 2024 02:22 ET